HU198940B - Process for producing neopodophyllotoxin derivatives - Google Patents
Process for producing neopodophyllotoxin derivatives Download PDFInfo
- Publication number
- HU198940B HU198940B HU864864A HU486488A HU198940B HU 198940 B HU198940 B HU 198940B HU 864864 A HU864864 A HU 864864A HU 486488 A HU486488 A HU 486488A HU 198940 B HU198940 B HU 198940B
- Authority
- HU
- Hungary
- Prior art keywords
- formula
- neopodophyllotoxin
- derivatives
- preparation
- producing
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 8
- -1 methylenedioxy group Chemical group 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 4
- 239000007868 Raney catalyst Substances 0.000 claims description 2
- 229910000564 Raney nickel Inorganic materials 0.000 claims description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 claims description 2
- 239000003054 catalyst Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 238000005984 hydrogenation reaction Methods 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 229910052697 platinum Inorganic materials 0.000 claims description 2
- 239000010948 rhodium Substances 0.000 claims description 2
- 229910052703 rhodium Inorganic materials 0.000 claims description 2
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 1
- 239000007858 starting material Substances 0.000 claims 1
- YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 abstract description 6
- YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 abstract description 5
- 239000000543 intermediate Substances 0.000 abstract description 5
- 229960001237 podophyllotoxin Drugs 0.000 abstract description 5
- YVCVYCSAAZQOJI-UHFFFAOYSA-N podophyllotoxin Natural products COC1=C(O)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YVCVYCSAAZQOJI-UHFFFAOYSA-N 0.000 abstract description 5
- 238000006243 chemical reaction Methods 0.000 abstract description 2
- 229940034982 antineoplastic agent Drugs 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetraline Natural products C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 description 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 229940045696 antineoplastic drug podophyllotoxin derivative Drugs 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 238000006264 debenzylation reaction Methods 0.000 description 1
- MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000003818 flash chromatography Methods 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 239000003600 podophyllotoxin derivative Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/353—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by isomerisation; by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Steroid Compounds (AREA)
Description
A találmány tárgya új eljárás (IX) általános képletű neopodofillotoxin-származékok előállítására; ezek a vegyületek értékes köztitermékek a (X) általános képletű podofillotoxin-származékok, ezen belül is az (I) képletű podofillotoxin előállítása során. A podofillotoxinnak és számos vele rokon szrkezetű aril-tetralinnak citotoxikus, antineoplasztikus hatása van (az etóposid például az (I) képletű vegyület 4/J-izomerjének egy glikozidja). A (IX) általános képletben
R1 és R2 együtt metilén-dioxi-csoportot ké&4és R6 jelentése egymástól függetlenül 1-4 szénatomos alkoxicsoport, s
R5 jelentése 1 — 4 szénatomos alkilcsoport.
A (IX) általános képletnek megfelelő neopodofillotoxin (ahol R4 és R6 metoxi- és R5 metilcsoport) előállítása /ld. J.Am.Chem.Soc 103 6208-9 (1981)/ kielégtítő hozammal csak visszakeringtető eljárások alkalmazásával volt megvalósítható, más úton (brómpiperonálból kiindulva a IC lépés hozama: 14,9%).
A (IX) általános képletű neopodofillotoxinszármazékokat találmányunk szerint úgy állítjuk elő, hogy egy általunk előállított új (VIII) általános képletű vegyületet - a képletben R1, R2, R4, R5 és R6 jelentése a fenti, R*° jelentése hidrogénatom, rövidszénláncú alkil-, rövidszénláncú alkoxi- vagy nitrocsoport - (ld. a párhuzamos 4863/88-as alapszámú bejelentésünkben) debenzilezünk. A debenzilezést a szokásos körülmények között végrehajtott hidrogénezéssel végezzük, katalizátor, úgymint platina, Raneynikkel, ródium alkalmazásával, oldószerben, úgymint tetrahidrofuránban, etanolban vagy etilacetátban.
A reakciót 0-50 ’C hőmérsékleten, előnyösen körülbelül 25 “C-on hajtjuk végre.
Leírásunkban az 1 — 4 szénatomos alkoxicsoport megjelölés alatt 1-4 szénatomos, egyenes vagy elágazó szénláncú alkilrészt tartalmazó alkoxicsoportot értünk; az alkilrész metil-, etil-, propil-, izopropil-, butil-, izobutil- vagy terc-butil-csoport. Ezek a csoportok előnyösen 1 vagy 2 szénatomot tartalmaznak.
A találmányunk szerint előállított (IX) általános képletű vegyületek felhasználását a podofillotoxin és származékai előállítására a T/47114 számon nyilvánosságrahozott magyar szabadalmi bejelentésünkben ismertetjük.
A találmány szerinti megoldást a következő, nem korlátozó példával szemléltetjük.
Az olvadáspont értékét Thomas-Hoover kaEilláris olvadáspontmérőben határoztuk meg és orrigálatlanul. adjuk meg. A proton NMRspektrumot Brukner WM 360 spektrométeren vettük fel, tetrametil-szilánt alkalmazva belső standardként. A infravörös spektrumot Nicolet 5DX FT IR-spektrofotométeren vettük fel. A kromatográfiás szétválasztást Woelm gyártmányú szilikagélen (0,040 - 0,063 mm) pillanatkromatográfiás módszerrel vagy 0,5 mm-es E-.Merck gyártmányú szilikagél lemezeken (60F-254) végeztük.
Példa
Neopodofillotoxin /(IX) általános képletű vegyület, amelyben R1 és R2 együtt metilén-dioxi-csoportot képez, R4 és R6 jelentése metoxicsoport, R5 jelentése metilcsoport/.
mg (0,16 mmól) neopodofillotoxin-benziléter /(VIII) általános képletű vegyület, amelyben R49 és R2 együtt metilén-dioxi-csoportot képez, R4 és R6 jelentése metoxicsoport, R5 jelentése metilcsoport, R10 jelentése hidrogénatom) 10 ml etil-acetáttal készített oldatát, amely néhány csepp metanolt és 40 mg 10%-os szénhordozós palládiumkatalizátort is tartalmaz, 2065 kPa hidrogénnyomáson és szobahőmérsékleten hidrogénezünk 3 órát. Ezután celite-en szűrjük, majd az oldószert lepároljuk, így fehér szilárd anyagot kapunk, amelyet szilícium-dioxid lemezeken kromatografálunk (futtatás diklór-metánnal), így 36 mg (55%) cím szerinti terméket kapuk, amelynek olvadáspontja 235 — 237 ’C.
NMR-spektrum (deutero-kloroformban) delta: 3,02 (t, 1H, J = 4,5 Hz), 3,17 (m, 1H), 3,67 (t, 1H, J = 4,8 Hz), 3,76 (m, 1H), 3.78 (s, 6H), 3,85 (s, 3H), 4,25 (d, 1H, J = 4,7 Hz), 5,18 (d, 1H, J = 4,8 Hz), 5,95 (d, 1H, J = 1,0 Hz), 5,97 (d, 1H, J -1,0 Hz), 6,27 (s, 2H), 6,49 (s, 1H), 6,74 (s, 1H).
IR-spektrum (kálium-bromid-pasztillában). 3425, 1764, 1592, 1508, 1489, 1333, 1240, 1125, 1037 cm·'.
Elemanalízis a C22H22O8x0,5H2O összegképlet alapján:
számított: C: 62,40, H: 5,47%; talált: C: 62,34, H: 5,22%.
Claims (3)
- Szabadalmi igénypontok1. Eljárás (IX) általános képletű neopodofillotoxi-származékok előállítására — a képletbenR1 és R2 együtt metilén-dioxi-csoportot képez,R4 és R6 jelentése egymástól függetlenül 1—4 szénatomos alkoxicsoport, ésR5 jelentése 1 — 4 szénatomos alkilcsoport — azzal jellemezve, hogy egy (VIII) általános képletű vegyületet — a képletben R1, R2, R4. R5 és R6 jelentése a tárgyi körben megadott, R10 jelentése hidrogénatom, rövidszénláncú alkil-, rövidszénláncú alkoxi- vagy nitrocsoport — hidrogénezünk.
- 2. Az 1. igénypont szerinti eljárás, azzal jellemezve, hogy a hidrogénezést platina-, Raney-nikkel- vagy ródium-katalizátor jelenlétében hajtjuk végre.
- 3. A 2. igénypont szerinti eljárás olyan (IX) általános képletű vegyületek előállítására, amelyeknek képletében R1 és R2 együtt metilén-dioxi-csoportot képez, R4 és R6 jelentése metoxicsoport, R5 jelentése metilcsoport, azzal jellemezve, hogy megfelelően helyettesített kiindulási anyagot alkalmazunk.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/805,484 US4734512A (en) | 1985-12-05 | 1985-12-05 | Intermediates for the production of podophyllotoxin and related compounds and processes for the preparation and use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUT48888A HUT48888A (en) | 1989-07-28 |
| HU198940B true HU198940B (en) | 1989-12-28 |
Family
ID=25191684
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU864862D HU198465B (en) | 1985-12-05 | 1986-12-04 | Process for producing 3-/benzyloxymethyl/-aryl-tetralone derivatives |
| HU864865A HUT47560A (en) | 1985-12-05 | 1986-12-04 | Process for production of enol-silil-esthers |
| HU864864A HU198940B (en) | 1985-12-05 | 1986-12-04 | Process for producing neopodophyllotoxin derivatives |
| HU865028A HU198938B (en) | 1985-12-05 | 1986-12-04 | Process for producing podophyllotoxin and podophyllotoxin derivatives |
| HU884863A HU198939B (en) | 1985-12-05 | 1986-12-04 | Process for producing neopodophyllotoxin benzylether derivatives |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU864862D HU198465B (en) | 1985-12-05 | 1986-12-04 | Process for producing 3-/benzyloxymethyl/-aryl-tetralone derivatives |
| HU864865A HUT47560A (en) | 1985-12-05 | 1986-12-04 | Process for production of enol-silil-esthers |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU865028A HU198938B (en) | 1985-12-05 | 1986-12-04 | Process for producing podophyllotoxin and podophyllotoxin derivatives |
| HU884863A HU198939B (en) | 1985-12-05 | 1986-12-04 | Process for producing neopodophyllotoxin benzylether derivatives |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US4734512A (hu) |
| EP (1) | EP0224938B1 (hu) |
| JP (1) | JPS62145093A (hu) |
| KR (1) | KR900004129B1 (hu) |
| AT (1) | ATE77380T1 (hu) |
| AU (2) | AU599937B2 (hu) |
| CA (4) | CA1318321C (hu) |
| DE (1) | DE3685727T2 (hu) |
| ES (1) | ES2042488T3 (hu) |
| GR (1) | GR3005053T3 (hu) |
| HU (5) | HU198465B (hu) |
| IL (3) | IL94000A (hu) |
| ZA (1) | ZA869184B (hu) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4644072A (en) * | 1985-04-12 | 1987-02-17 | Bristol-Myers Company | Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof |
| US5011948A (en) * | 1985-04-12 | 1991-04-30 | Bristol-Myers Company | Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof |
| US4734512A (en) * | 1985-12-05 | 1988-03-29 | Bristol-Myers Company | Intermediates for the production of podophyllotoxin and related compounds and processes for the preparation and use thereof |
| JPS6393796A (ja) * | 1986-10-09 | 1988-04-25 | Shin Etsu Chem Co Ltd | ペプチド合成の脱保護基用薬剤 |
| GB9422946D0 (en) * | 1994-11-14 | 1995-01-04 | Univ Salamanca | Antineoplastic cyclolignan derivatives |
| AU2005285953B2 (en) | 2004-09-22 | 2011-01-20 | Nippon Kayaku Kabushiki Kaisha | Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient |
| KR20080106254A (ko) | 2006-03-28 | 2008-12-04 | 니폰 가야꾸 가부시끼가이샤 | 탁산류의 고분자 결합체 |
| WO2007135910A1 (ja) * | 2006-05-18 | 2007-11-29 | Nippon Kayaku Kabushiki Kaisha | ポドフィロトキシン類の高分子結合体 |
| CA2664852A1 (en) * | 2006-10-03 | 2008-04-10 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight conjugate of resorcinol derivatives |
| US8334364B2 (en) | 2006-11-06 | 2012-12-18 | Nipon Kayaku Kabushiki Kaisha | High-molecular weight derivative of nucleic acid antimetabolite |
| EP2090607B1 (en) | 2006-11-08 | 2015-05-20 | Nippon Kayaku Kabushiki Kaisha | Polymeric derivative of nucleic acid metabolic antagonist |
| WO2009041570A1 (ja) * | 2007-09-28 | 2009-04-02 | Nippon Kayaku Kabushiki Kaisha | ステロイド類の高分子結合体 |
| US8920788B2 (en) * | 2008-03-18 | 2014-12-30 | Nippon Kayaku Kabushiki Kaisha | High-molecular weight conjugate of physiologically active substances |
| EP2284209B1 (en) | 2008-05-08 | 2016-08-31 | Nippon Kayaku Kabushiki Kaisha | Polymer conjugate of folic acid or folic acid derivative |
| CN102421827B (zh) | 2009-05-15 | 2014-07-30 | 日本化药株式会社 | 具有羟基的生理活性物质的高分子结合体 |
| KR20140024833A (ko) | 2010-11-17 | 2014-03-03 | 니폰 가야꾸 가부시끼가이샤 | 신규한 시티딘계 대사길항제의 고분자 유도체 |
| RU2623426C2 (ru) | 2011-09-11 | 2017-06-26 | Ниппон Каяку Кабусики Кайся | Способ получения блок-сополимера |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4294763A (en) * | 1980-03-05 | 1981-10-13 | University Of Rochester | Intermediates for the production of picropodophyllin and related compounds and processes for the preparation and use thereof |
| US4391982A (en) * | 1980-03-05 | 1983-07-05 | The University Of Rochester | Intermediates for the production of picropodophyllin and related compounds and processes for the preparation and use thereof |
| US4644072A (en) * | 1985-04-12 | 1987-02-17 | Bristol-Myers Company | Intermediates for the production of epipodophyllotoxin and related compounds and processes for the preparation and use thereof |
| US4734512A (en) * | 1985-12-05 | 1988-03-29 | Bristol-Myers Company | Intermediates for the production of podophyllotoxin and related compounds and processes for the preparation and use thereof |
-
1985
- 1985-12-05 US US06/805,484 patent/US4734512A/en not_active Expired - Fee Related
-
1986
- 1986-12-01 AU AU65870/86A patent/AU599937B2/en not_active Ceased
- 1986-12-03 IL IL94000A patent/IL94000A/xx unknown
- 1986-12-03 IL IL80853A patent/IL80853A/xx not_active IP Right Cessation
- 1986-12-03 IL IL93999A patent/IL93999A/xx unknown
- 1986-12-04 HU HU864862D patent/HU198465B/hu not_active IP Right Cessation
- 1986-12-04 HU HU864865A patent/HUT47560A/hu not_active IP Right Cessation
- 1986-12-04 HU HU864864A patent/HU198940B/hu not_active IP Right Cessation
- 1986-12-04 CA CA000524593A patent/CA1318321C/en not_active Expired - Fee Related
- 1986-12-04 HU HU865028A patent/HU198938B/hu not_active IP Right Cessation
- 1986-12-04 HU HU884863A patent/HU198939B/hu not_active IP Right Cessation
- 1986-12-04 JP JP61289727A patent/JPS62145093A/ja active Pending
- 1986-12-04 KR KR1019860010378A patent/KR900004129B1/ko not_active IP Right Cessation
- 1986-12-04 ZA ZA869184A patent/ZA869184B/xx unknown
- 1986-12-05 AT AT86116961T patent/ATE77380T1/de active
- 1986-12-05 DE DE8686116961T patent/DE3685727T2/de not_active Expired - Fee Related
- 1986-12-05 ES ES86116961T patent/ES2042488T3/es not_active Expired - Lifetime
- 1986-12-05 EP EP86116961A patent/EP0224938B1/en not_active Expired - Lifetime
-
1987
- 1987-12-07 US US07/129,795 patent/US4845248A/en not_active Expired - Fee Related
-
1990
- 1990-06-15 AU AU57151/90A patent/AU631216B2/en not_active Ceased
-
1992
- 1992-04-15 CA CA000616355A patent/CA1321596C/en not_active Expired - Fee Related
- 1992-04-15 CA CA000616353A patent/CA1321595C/en not_active Expired - Fee Related
- 1992-04-15 CA CA000616352A patent/CA1321597C/en not_active Expired - Fee Related
- 1992-06-30 GR GR920401381T patent/GR3005053T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0224938A3 (en) | 1989-11-02 |
| IL94000A (en) | 1991-09-16 |
| CA1321597C (en) | 1993-08-24 |
| EP0224938A2 (en) | 1987-06-10 |
| DE3685727D1 (de) | 1992-07-23 |
| CA1321595C (en) | 1993-08-24 |
| HUT47114A (en) | 1989-01-30 |
| AU631216B2 (en) | 1992-11-19 |
| CA1321596C (en) | 1993-08-24 |
| IL93999A (en) | 1991-09-16 |
| HUT48888A (en) | 1989-07-28 |
| IL94000A0 (en) | 1991-01-31 |
| CA1318321C (en) | 1993-05-25 |
| AU5715190A (en) | 1990-10-04 |
| GR3005053T3 (hu) | 1993-05-24 |
| EP0224938B1 (en) | 1992-06-17 |
| HUT47560A (en) | 1989-03-28 |
| KR900004129B1 (ko) | 1990-06-16 |
| AU6587086A (en) | 1987-06-11 |
| US4734512A (en) | 1988-03-29 |
| IL80853A (en) | 1991-09-16 |
| DE3685727T2 (de) | 1993-01-21 |
| HU198938B (en) | 1989-12-28 |
| ES2042488T3 (es) | 1993-12-16 |
| HU198939B (en) | 1989-12-28 |
| HUT48878A (en) | 1989-07-28 |
| ZA869184B (en) | 1987-07-29 |
| HUT47559A (en) | 1989-03-28 |
| KR870006032A (ko) | 1987-07-08 |
| AU599937B2 (en) | 1990-08-02 |
| IL93999A0 (en) | 1991-01-31 |
| HU198465B (en) | 1989-10-30 |
| US4845248A (en) | 1989-07-04 |
| ATE77380T1 (de) | 1992-07-15 |
| JPS62145093A (ja) | 1987-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU198940B (en) | Process for producing neopodophyllotoxin derivatives | |
| Schmid et al. | Synthetic studies on polyether antibiotics. 4. Total synthesis of monensin. 1. Stereocontrolled synthesis of the left half of monensin | |
| US5847142A (en) | Preparation of narcotic analgesics | |
| US4239683A (en) | Pyrrolo benzodiazepine compounds | |
| Lee et al. | Synthesis of mono-and unsymmetrical bis-orthoesters of scyllo-inositol | |
| US6660856B2 (en) | Synthesis of pyrrolo[2,1-c][1,4]benzodiazepine analogues | |
| US4778891A (en) | Certain pyrano (3,4-f)-indolizine derivatives | |
| US3755333A (en) | Process for the preparation of vincamine | |
| EP0670839B1 (en) | Process for the preparation of 9-amino camptothecin | |
| Holton et al. | Palladium-mediated biomimetic synthesis of narwedine | |
| WO1994029310A1 (en) | Process for asymmetric total synthesis of camptothecin | |
| Kuehne et al. | Total syntheses of tubotaiwine and 19, 20-dihydro-20-epi-akuammicine | |
| US4316029A (en) | Synthesis of vincaminic acid derivatives | |
| Miyakado et al. | Trichoclin, a new furocoumarin from Trichocline incana | |
| Banks et al. | A new synthesis of indolo [2, 3-α] quinolizidine derivatives: A formal total synthesis of (±)-geissoschizine | |
| Greenwood et al. | 2-Aryloxymethyl-2, 3, 5, 6-tetrahydro-1, 4-oxazines, a new class of antidepressants | |
| OKAMURA et al. | Stereochemical Studies. LIII. An Asymmetric Synthesis of (3S 15S 20R)-Yohimbone from L-Tryptophan by 1, 3-Transfer of Asymmetry | |
| Lira et al. | Synthesis and complete assignments of 1H and 13C NMR spectra of mesoionic 2-(ptrifluoromethylphenyl)-3-methyl-4-(p-tolyl)-1, 3-thiazolium-5-thiolate and 2-(p-chlorophenyl)-3-methyl–4-(p-isopropylphenyl)-1, 3-thiazolium-5-thiolate | |
| EP0598383B1 (en) | Process for the preparation of 5,6-diacetoxyindole | |
| US4064173A (en) | 9,10-Seco-steroids | |
| EP0331320B1 (en) | New alkaloid compounds, pharmaceutical compositions and their methods of use | |
| DAUZONNE et al. | A Versatile Synthesis of 1-Aryl-2-nitro-3-(3, 4-, 5-trimethoxyphenyl)-propenes as Precursors of Novel Mescaline Derivatives | |
| EP0050492A1 (en) | 1,1-Disubstituted-hexahydro-indolo(2,3-a)quinolizine derivatives and their use in the enantioselective synthesis of optically active 14-oxo-E-homo-eburnane derivatives | |
| SAWA et al. | Studies on the Syntheses of Analgesics. V. Synthesis of 1, 2, 3, 4, 5, 6-Hexahydro-3-benzazocine Derivatives.(3) | |
| Curran | Investigations toward the total syntheses of proapoiphine and homoproaporphine alkaloids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HU90 | Patent valid on 900628 | ||
| HMM4 | Cancellation of final prot. due to non-payment of fee |